{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:15:42Z","timestamp":1793153742621,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>During the last decades, gestational diabetes mellitus (GDM) prevalence has been on the rise. While insulin remains the gold standard treatment for GDM, metformin use during pregnancy is controversial. This review aimed to comprehensively assess the available data on the efficacy and safety of metformin during pregnancy, both for the mother and the offspring. Metformin has been validated for maternal efficacy and safety, achieving comparable glycemic control with insulin. Additionally, it reduces maternal weight gain and possibly the occurrence of hypertensive disorders. During the early neonatal period, metformin administration does not increase the risk of congenital anomalies or other major adverse effects, including lower APGAR score at 5\u2009min, neonatal intensive care unit admissions, and respiratory distress syndrome. Several studies have demonstrated a reduction in neonatal hypoglycemia. Metformin has been associated with an increase in preterm births and lower birth weight, although this effect is controversial and depends on the indication for which it was administered. Evidence indicates possible altered fetal programming and predisposition to childhood obesity and metabolic syndrome during adulthood after use of metformin in pregnancy. With critical questions still requiring a final verdict, ongoing research on the field must be conducted.<\/jats:p>","DOI":"10.1007\/s12020-023-03550-0","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T18:02:27Z","timestamp":1696528947000},"page":"259-269","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Efficacy and safety of metformin during pregnancy: an update"],"prefix":"10.1007","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0651-1376","authenticated-orcid":false,"given":"Stavroula A.","family":"Paschou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0924-3642","authenticated-orcid":false,"given":"Almog","family":"Shalit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4539-8319","authenticated-orcid":false,"given":"Eleni","family":"Gerontiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0811-8156","authenticated-orcid":false,"given":"Kleoniki I.","family":"Athanasiadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Kalampokas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1404-9716","authenticated-orcid":false,"given":"Theodora","family":"Psaltopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Lambrinoudaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Anastasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce H. R.","family":"Wolffenbuttel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5005-1995","authenticated-orcid":false,"given":"Dimitrios G.","family":"Goulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"3550_CR1","doi-asserted-by":"publisher","first-page":"232","DOI":"10.2337\/dc22-S015","volume":"45","author":"American Diabetes Association Professional Practice Committee: 15","year":"2022","unstructured":"American Diabetes Association Professional Practice Committee: 15, Management of diabetes in pregnancy: standards of medical care in diabetes-2022. Diabetes Care 45, 232\u201343 (2022). https:\/\/doi.org\/10.2337\/dc22-S015","journal-title":"Diabetes Care"},{"key":"3550_CR2","doi-asserted-by":"publisher","unstructured":"IDF Diabetes Atlas. Int. Diabetes Fed. (2021). https:\/\/doi.org\/10.1016\/j.diabres.2013.10.013","DOI":"10.1016\/j.diabres.2013.10.013"},{"key":"3550_CR3","unstructured":"National Institute for Health and Care Excellence (NICE). Diabetes in Pregnancy: Management of Diabetes and its Complications from Pre-conception to the Postnatal Period (NG3), NG3 edn. (National Institute for Health and Care Excellence, 2015) https:\/\/www.nice.org.uk\/guidance\/ng3"},{"key":"3550_CR4","doi-asserted-by":"publisher","unstructured":"Diabetes Canada Clinical Practice Guidelines Expert Committee, D.S. Feig, H. Berger, L. Donovan, A. Godbout, T. Kader, E. Keely et al. Diabetes and pregnancy. Can. J. Diabetes 42, 255\u201382 (2018). https:\/\/doi.org\/10.1016\/j.jcjd.2017.10.038","DOI":"10.1016\/j.jcjd.2017.10.038"},{"key":"3550_CR5","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1016\/S0020-7292(15)30007-2","volume":"131","author":"M Hod","year":"2015","unstructured":"M. Hod, A. Kapur, D.A. Sacks, E. Hadar, M. Agarwal, G.C. Di Renzo et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on Gestational Diabetes Mellitus: a pragmatic guide for diagnosis, management, and care. Int. J. Gynecol. Obstet. 131, S173\u2013211 (2015)","journal-title":"Int. J. Gynecol. Obstet."},{"key":"3550_CR6","doi-asserted-by":"publisher","unstructured":"S.A. Paschou, E. Bletsa, M. Papazisi, N. Mili, F. Kanouta, G.N. Kassi et al. Screening and management of major endocrinopathies during pregnancy: an update. Endocrine 1\u201310 (2022). https:\/\/doi.org\/10.1007\/S12020-022-03237-Y\/TABLES\/2","DOI":"10.1007\/S12020-022-03237-Y\/TABLES\/2"},{"key":"3550_CR7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1001\/JAMA.2021.11922","volume":"326","author":"KW Davidson","year":"2021","unstructured":"K.W. Davidson, M.J. Barry, C.M. Mangione, M. Cabana, A.B. Caughey, E.M. Davis et al. Screening for gestational diabetes: US Preventive Services Task Force recommendation statement. JAMA 326, 531\u2013538 (2021). https:\/\/doi.org\/10.1001\/JAMA.2021.11922","journal-title":"JAMA"},{"key":"3550_CR8","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","volume":"358","author":"JA Rowan","year":"2008","unstructured":"J.A. Rowan, W.M. Hague, W. Gao, M.R. Battin, M. Peter Moore, Metformin versus insulin for the treatment of gestational diabetes. N. Engl. J. Med. 358, 2003\u201318 (2008)","journal-title":"N. Engl. J. Med."},{"key":"3550_CR9","doi-asserted-by":"publisher","unstructured":"J.A. Ainuddin, N. Karim, S. Zaheer, S. Sanwer Ali, A. Ara Hasan, Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel-group, randomized, open label study in patients with type 2 diabetes in pregnancy. (2015). https:\/\/doi.org\/10.1155\/2015\/325851","DOI":"10.1155\/2015\/325851"},{"key":"3550_CR10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/J.DIABRES.2014.10.001","volume":"107","author":"JA Ainuddin","year":"2015","unstructured":"J.A. Ainuddin, N. Karim, A.A. Hasan, S.A. Naqvi, Metformin versus insulin treatment in gestational diabetes in pregnancy in a developing country: a randomized control trial. Diabetes Res. Clin. Pract. 107, 290\u20139 (2015). https:\/\/doi.org\/10.1016\/J.DIABRES.2014.10.001","journal-title":"Diabetes Res. Clin. Pract."},{"key":"3550_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2165\/00003088-200342040-00001","volume":"42","author":"F Garcia-Bournissen","year":"2003","unstructured":"F. Garcia-Bournissen, D.S. Feig, G. Koren, Maternal-fetal transport of hypoglycaemic drugs. Clin. Pharmacokinet. 42, 303\u201313 (2003). https:\/\/doi.org\/10.2165\/00003088-200342040-00001","journal-title":"Clin. Pharmacokinet."},{"key":"3550_CR12","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/S00592-023-02137-5\/TABLES\/15","volume":"60","author":"L Sciacca","year":"2023","unstructured":"L. Sciacca, C. Bianchi, S. Burlina, G. Formoso, E. Manicardi, M.A. Sculli et al. Position paper of the Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), and the Italian Study Group of Diabetes in pregnancy: metformin use in pregnancy. Acta Diabetol. 60, 1421\u201337 (2023). https:\/\/doi.org\/10.1007\/S00592-023-02137-5\/TABLES\/15","journal-title":"Acta Diabetol."},{"key":"3550_CR13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/S42000-020-00192-Z","volume":"19","author":"E Anastasiou","year":"2020","unstructured":"E. Anastasiou, G. Farmakidis, A. Gerede, D.G. Goulis, E. Koukkou, A. Kourtis et al. Clinical practice guidelines on diabetes mellitus and pregnancy: \u0399. Pre-existing type 1 and type 2 diabetes mellitus. Hormones 19, 593\u2013600 (2020). https:\/\/doi.org\/10.1007\/S42000-020-00192-Z","journal-title":"Hormones"},{"key":"3550_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/S42000-020-00193-Y","volume":"19","author":"E Anastasiou","year":"2020","unstructured":"E. Anastasiou, G. Farmakidis, A. Gerede, D.G. Goulis, E. Koukkou, A. Kourtis et al. Clinical practice guidelines on diabetes mellitus and pregnancy: \u0399I. Gestational diabetes mellitus. Hormones 19, 601\u20137 (2020). https:\/\/doi.org\/10.1007\/S42000-020-00193-Y","journal-title":"Hormones"},{"key":"3550_CR15","unstructured":"Hellenic Diabetes Association, G. Dimitriadis, I. Ioannidis, K. Makrilakis, A. Mavrogiannaki, A. Melidonis, I. Migdalis et al. Guidelines for Diabetes Mellitus. 5 (2023). https:\/\/www.ede.gr"},{"key":"3550_CR16","doi-asserted-by":"publisher","unstructured":"J.M. Dodd, R.M. Grivell, A.R. Deussen, W.M., Hague, Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes. Cochrane Database Syst. Rev. (2018). https:\/\/doi.org\/10.1002\/14651858.CD010564.pub2","DOI":"10.1002\/14651858.CD010564.pub2"},{"key":"3550_CR17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/NEJMOA1509819\/SUPPL_FILE\/NEJMOA1509819_DISCLOSURES.PDF","volume":"374","author":"A Syngelaki","year":"2016","unstructured":"A. Syngelaki, K.H. Nicolaides, J. Balani, S. Hyer, R. Akolekar, R. Kotecha et al. Metformin versus placebo in obese pregnant women without diabetes mellitus. N. Engl. J. Med. 374, 434\u201343 (2016). https:\/\/doi.org\/10.1056\/NEJMOA1509819\/SUPPL_FILE\/NEJMOA1509819_DISCLOSURES.PDF","journal-title":"N. Engl. J. Med."},{"key":"3550_CR18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S2213-8587(15)00219-3","volume":"3","author":"C Chiswick","year":"2015","unstructured":"C. Chiswick, R.M. Reynolds, F. Denison, A.J. Drake, S. Forbes, D.E. Newby et al. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 3, 778\u201386 (2015). https:\/\/doi.org\/10.1016\/S2213-8587(15)00219-3","journal-title":"Lancet Diabetes Endocrinol."},{"key":"3550_CR19","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1136\/BMJDRC-2021-002363","volume":"10","author":"KMG Brand","year":"2022","unstructured":"K.M.G. Brand, L. Saarelainen, J. Sonajalg, E. Boutmy, C. Foch, M. V\u00e4\u00e4r\u00e4sm\u00e4ki et al. Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study. BMJ Open Diabetes Res. Care. 10, 2363 (2022). https:\/\/doi.org\/10.1136\/BMJDRC-2021-002363","journal-title":"BMJ Open Diabetes Res. Care."},{"key":"3550_CR20","doi-asserted-by":"publisher","first-page":"9084708","DOI":"10.1155\/2019\/9804708","volume":"2019","author":"L Guo","year":"2019","unstructured":"L. Guo, J. Ma, J. Tang, D. Hu, W. Zhang, X. Zhao Comparative efficacy and safety of metformin, glyburide, and insulin in treating gestational diabetes mellitus: a meta-analysis. J. Diabetes Res. 2019, 9084708 (2019). https:\/\/doi.org\/10.1155\/2019\/9804708","journal-title":"J. Diabetes Res."},{"key":"3550_CR21","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/J.FERTNSTERT.2006.02.098","volume":"86","author":"C Gilbert","year":"2006","unstructured":"C. Gilbert, M. Valois, G. Koren, Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil. Steril. 86, 658\u201363 (2006). https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2006.02.098","journal-title":"Fertil. Steril."},{"key":"3550_CR22","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1136\/BMJDRC-2017-000456","volume":"6","author":"JA Rowan","year":"2018","unstructured":"J.A. Rowan, E.C. Rush, L.D. Plank, J. Lu, V. Obolonkin, S. Coat et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7\u20139 years of age. BMJ Open Diabetes Res. Care. 6, 456 (2018). https:\/\/doi.org\/10.1136\/BMJDRC-2017-000456","journal-title":"BMJ Open Diabetes Res. Care."},{"key":"3550_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S2352-4642(18)30385-7","volume":"3","author":"LGE Hanem","year":"2019","unstructured":"L.G.E. Hanem, \u00d8. Salvesen, P.B. Juliusson, S.M. Carlsen, M.C.F. Nossum, M.\u00d8. Vaage et al. Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5\u201310 year follow-up of the PregMet randomised controlled trial. Lancet Child Adolesc. Health 3, 166\u201374 (2019). https:\/\/doi.org\/10.1016\/S2352-4642(18)30385-7","journal-title":"Lancet Child Adolesc. Health"},{"key":"3550_CR24","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S2213-8587(19)30002-6","volume":"7","author":"TS L\u00f8vvik","year":"2019","unstructured":"T.S. L\u00f8vvik, S.M. Carlsen, \u00d8. Salvesen, B. Steffensen, M. Bixo, F. G\u00f3mez-Real et al. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 7, 256\u201366 (2019). https:\/\/doi.org\/10.1016\/S2213-8587(19)30002-6","journal-title":"Lancet Diabetes Endocrinol."},{"key":"3550_CR25","doi-asserted-by":"publisher","unstructured":"L.-P. Zhao, X.-Y. Sheng, S. Zhou, T. Yang, L.-Y. Ma, Y. Zhou et al. Metformin versus insulin for gestational diabetes mellitus: a meta-analysis (2015). https:\/\/doi.org\/10.1111\/bcp.12672","DOI":"10.1111\/bcp.12672"},{"key":"3550_CR26","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/DOM.12017","volume":"15","author":"K Tertti","year":"2013","unstructured":"K. Tertti, U. Ekblad, P. Koskinen, T. Vahlberg, T. R\u00f6nnemaa, Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin. Diabetes Obes. Metab. 15, 246\u201351 (2013). https:\/\/doi.org\/10.1111\/DOM.12017","journal-title":"Diabetes Obes. Metab."},{"key":"3550_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/J.EPAG.2018.01.002","volume":"66","author":"SR Eid","year":"2018","unstructured":"S.R. Eid, R.S.I. Moustafa, M.M. Salah, S.K. Hanafy, R.H. Aly, W.F.G. Mostafa et al. Is metformin a viable alternative to insulin in the treatment of gestational diabetes mellitus (GDM)? Comparison of maternal and neonatal outcomes. Egypt Pediatr. Assoc. Gaz 66, 15\u201321 (2018). https:\/\/doi.org\/10.1016\/J.EPAG.2018.01.002","journal-title":"Egypt Pediatr. Assoc. Gaz"},{"key":"3550_CR28","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1080\/14767058.2016.1228061","volume":"30","author":"Y Feng","year":"2017","unstructured":"Y. Feng, H. Yang, Metformin\u2013a potentially effective drug for gestational diabetes mellitus: a systematic review and meta-analysis. J. Matern. Fetal Neonatal Med. 30, 1874\u201381 (2017). https:\/\/doi.org\/10.1080\/14767058.2016.1228061","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"3550_CR29","doi-asserted-by":"publisher","unstructured":"J. Gui, Q. Liu, L. Feng, Metformin vs insulin in the management of gestational diabetes: a meta-analysis. PLoS ONE 8 (2013). https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0064585","DOI":"10.1371\/JOURNAL.PONE.0064585"},{"key":"3550_CR30","doi-asserted-by":"publisher","unstructured":"M. Balsells, A. Garc\u00eda-Patterson, I. Sol\u00e0, M. Roqu\u00e9, I. Gich, R. Corcoy, Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ 350 (2015). https:\/\/doi.org\/10.1136\/BMJ.H102","DOI":"10.1136\/BMJ.H102"},{"key":"3550_CR31","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S2213-8587(20)30310-7","volume":"8","author":"DS Feig","year":"2020","unstructured":"D.S. Feig, L.E. Donovan, B. Zinman, J.J. Sanchez, E. Asztalos, E.A. Ryan et al. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 8, 834\u201344 (2020). https:\/\/doi.org\/10.1016\/S2213-8587(20)30310-7","journal-title":"Lancet Diabetes Endocrinol."},{"key":"3550_CR32","doi-asserted-by":"publisher","unstructured":"S.M. Carlsen, M.P. Martinussen, E. Vanky, Metformin\u2019s effect on first-year weight gain: a follow-up study. Pediatrics 130 (2012). https:\/\/doi.org\/10.1542\/peds.2012-0346.","DOI":"10.1542\/peds.2012-0346"},{"key":"3550_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/aogs.12788","volume":"95","author":"O Pellonper\u00e4","year":"2016","unstructured":"O. Pellonper\u00e4, T. R\u00f6nemma, U. Ekblad, T. Vahlberg, K. Tertti, The effects of metformin treatment of gestational diabetes on maternal. Acta Obstet. Gynecol. Scand 95, 79\u201387 (2016). https:\/\/doi.org\/10.1111\/aogs.12788","journal-title":"Acta Obstet. Gynecol. Scand"},{"key":"3550_CR34","doi-asserted-by":"publisher","unstructured":"M. Jahanshahi, A.R. Shahmirzadi, E. Kashani, R. Alipoor, S. Vosough, Effects of metformin and insulin therapy regimens on postpartum oral glucose tolerance test results in pregnant women with gestational diabetes mellitus: a comparative study. Horm. Mol. Biol. Clin. Investig. 41 (2020). https:\/\/doi.org\/10.1515\/hmbci-2020-0018","DOI":"10.1515\/hmbci-2020-0018"},{"key":"3550_CR35","doi-asserted-by":"publisher","unstructured":"F. Dunne, C. Newman, D. Devane, A. Smyth, A. Alvarez-Iglesias, P. Gillespie et al. A randomised placebo-controlled trial of the effectiveness of early metformin in addition to usual care in the reduction of gestational diabetes mellitus effects (EMERGE): study protocol. Trials 23 (2022). https:\/\/doi.org\/10.1186\/S13063-022-06694-Y","DOI":"10.1186\/S13063-022-06694-Y"},{"key":"3550_CR36","unstructured":"ClinicalTrials.gov, Metabolic analysis for treatment choice in gestational diabetes mellitus - full text view (n.d). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03029702. Accessed 24 Jan 2023."},{"key":"3550_CR37","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1055\/S-0039-1700796","volume":"41","author":"MLR De Souza","year":"2019","unstructured":"M.L.R. De Souza, R.R.E. Silva, T.R.E. Silva, L.C. De Oliveira, G. Dienstmann, I.B. Do Nascimento et al. Factors associated with the need for insulin as a complementary treatment to metformin in gestational diabetes mellitus. Revisita Bras. Ginecol. Obstet. 41, 697\u2013702 (2019). https:\/\/doi.org\/10.1055\/S-0039-1700796","journal-title":"Revisita Bras. Ginecol. Obstet."},{"key":"3550_CR38","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000515893","volume":"86","author":"X Wang","year":"2021","unstructured":"X. Wang, W. Liu, H. Chen, Q. Chen, Comparison of insulin, metformin, and glyburide on perinatal complications of gestational diabetes mellitus: a systematic review and meta-analysis. Gynecol. Obstet. Invest. 86, 218\u201330 (2021). https:\/\/doi.org\/10.1159\/000515893","journal-title":"Gynecol. Obstet. Invest."},{"key":"3550_CR39","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/J.1447-0756.2011.01659.X","volume":"38","author":"R Gorgal","year":"2012","unstructured":"R. Gorgal, E. Gon\u00e7alves, M. Barros, G. Namora, \u00c2. Magalh\u00e3es, T. Rodrigues et al. Gestational diabetes mellitus: a risk factor for non-elective cesarean section. J. Obstet. Gynaecol. Res. 38, 154\u20139 (2012). https:\/\/doi.org\/10.1111\/J.1447-0756.2011.01659.X","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"3550_CR40","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/J.TJOG.2015.08.024","volume":"55","author":"D Boriboonhirunsarn","year":"2016","unstructured":"D. Boriboonhirunsarn, R. Waiyanikorn, Emergency cesarean section rate between women with gestational diabetes and normal pregnant women. Taiwan J. Obstet. Gynecol. 55, 64\u20137 (2016). https:\/\/doi.org\/10.1016\/J.TJOG.2015.08.024","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"3550_CR41","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/J.AJOG.2004.06.057","volume":"191","author":"HM Ehrenberg","year":"2004","unstructured":"H.M. Ehrenberg, C.P. Durnwald, P. Catalano, B.M. Mercer, The influence of obesity and diabetes on the risk of cesarean delivery. Am. J. Obstet. Gynecol. 191, 969\u201374 (2004). https:\/\/doi.org\/10.1016\/J.AJOG.2004.06.057","journal-title":"Am. J. Obstet. Gynecol."},{"key":"3550_CR42","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/HUMUPD\/DMV029","volume":"21","author":"S Palomba","year":"2015","unstructured":"S. Palomba, M.A. De Wilde, A. Falbo, M.P.H. Koster, G.B. La Sala, B.C.J.M. Fauser, Pregnancy complications in women with polycystic ovary syndrome. Hum. Reprod. Update 21, 575\u201392 (2015). https:\/\/doi.org\/10.1093\/HUMUPD\/DMV029","journal-title":"Hum. Reprod. Update"},{"key":"3550_CR43","doi-asserted-by":"publisher","unstructured":"E. Vanky, S. Stridsklev, R. Heimstad, P. Romundstad, K. Skog\u00f8y, O. Kleggetveit et al. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study (2010). https:\/\/doi.org\/10.1210\/jc.2010-0853","DOI":"10.1210\/jc.2010-0853"},{"key":"3550_CR44","doi-asserted-by":"publisher","unstructured":"X.-L. Zeng, Y.-F. Zhang, Q. Tian, Y. Xue, R.-F. An, Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome A meta-analysis. Medicine 95 (2016). https:\/\/doi.org\/10.1097\/MD.0000000000004526","DOI":"10.1097\/MD.0000000000004526"},{"key":"3550_CR45","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejogrb.2011.03.024","volume":"157","author":"V De Leo","year":"2011","unstructured":"V. De Leo, M.C. Musacchio, P. Piomboni, A. Di Sabatino, G. Morgante, The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications. Eur. J. Obstet. Gynecol. Reprod. Biol. 157, 63\u20136 (2011). https:\/\/doi.org\/10.1016\/j.ejogrb.2011.03.024","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"3550_CR46","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1093\/HUMREP\/17.11.2858","volume":"17","author":"CJ Glueck","year":"2002","unstructured":"C.J. Glueck, P. Wang, N. Goldenberg, L. Sieve-Smith, Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum. Reprod. 17, 2858\u201364 (2002). https:\/\/doi.org\/10.1093\/HUMREP\/17.11.2858","journal-title":"Hum. Reprod."},{"key":"3550_CR47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S2213-8587(18)30310-3","volume":"7","author":"JM Dodd","year":"2019","unstructured":"J.M. Dodd, J. Louise, A.R. Deussen, R.M. Grivell, G. Dekker, A.J. McPhee et al. Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 7, 15\u201324 (2019). https:\/\/doi.org\/10.1016\/S2213-8587(18)30310-3","journal-title":"Lancet Diabetes Endocrinol."},{"key":"3550_CR48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/JOG.13477","volume":"44","author":"E Vald\u00e9s","year":"2018","unstructured":"E. Vald\u00e9s, A. Sep\u00falveda-Mart\u00ednez, P. Candia, N. Abusada, R. Orellana, B. Manukian et al. Metformin as a prophylactic treatment of gestational diabetes in pregnant patients with pregestational insulin resistance: a randomized study. J. Obstet. Gynaecol. Res. 44, 81\u20136 (2018). https:\/\/doi.org\/10.1111\/JOG.13477","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"3550_CR49","doi-asserted-by":"publisher","first-page":"e12964","DOI":"10.1111\/OBR.12964","volume":"21","author":"SAR Doi","year":"2020","unstructured":"S.A.R. Doi, L. Furuya-Kanamori, E. Toft, O.A.H. Musa, N. Islam, J. Clark et al. Metformin in pregnancy to avert gestational diabetes in women at high risk: Meta-analysis of randomized controlled trials. Obes. Rev. 21, e12964 (2020). https:\/\/doi.org\/10.1111\/OBR.12964","journal-title":"Obes. Rev."},{"key":"3550_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-88650-5","volume":"111","author":"JL Tarry-Adkins","year":"2021","unstructured":"J.L. Tarry-Adkins, S.E. Ozanne, C.E. Aiken, Impact of metformin treatment during pregnancy on maternal outcomes: a systematic review\/meta-analysis. Sci. Rep. 111, 1\u201313 (2021). https:\/\/doi.org\/10.1038\/s41598-021-88650-5","journal-title":"Sci. Rep."},{"key":"3550_CR51","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1055\/S-0028-1110084","volume":"26","author":"S Joy","year":"2009","unstructured":"S. Joy, N. Istwan, D. Rhea, C. Desch, G. Stanziano, The impact of maternal obesity on the incidence of adverse pregnancy outcomes in high-risk term pregnancies. Am. J. Perinatol. 26, 345\u20139 (2009). https:\/\/doi.org\/10.1055\/S-0028-1110084","journal-title":"Am. J. Perinatol."},{"key":"3550_CR52","unstructured":"Clinical Trials Register - Search for eudract_number:2018-000003-16 (n.d). https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2018-000003-16. Accessed 24 Jan 2023"},{"key":"3550_CR53","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/J.REPROTOX.2018.05.007","volume":"80","author":"O Diav-Citrin","year":"2018","unstructured":"O. Diav-Citrin, S. Steinmetz-Shoob, S. Shechtman, A. Ornoy, In-utero exposure to metformin for type 2 diabetes or polycystic ovary syndrome: a prospective comparative observational study. Reprod. Toxicol. 80, 85\u201391 (2018). https:\/\/doi.org\/10.1016\/J.REPROTOX.2018.05.007","journal-title":"Reprod. Toxicol."},{"key":"3550_CR54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/J.REPROTOX.2018.07.004","volume":"81","author":"S Scherneck","year":"2018","unstructured":"S. Scherneck, N. Schlinke, E. Beck, K. Grupe, C. Weber-Schoendorfer, C. Schaefer, Pregnancy outcome after first-trimester exposure to metformin: a prospective cohort study. Reprod. Toxicol. 81, 79\u201383 (2018). https:\/\/doi.org\/10.1016\/J.REPROTOX.2018.07.004","journal-title":"Reprod. Toxicol."},{"key":"3550_CR55","doi-asserted-by":"publisher","unstructured":"S.F. Lin, S.H. Chang, C.-F. Kuo, W.-T. Lin, M.-J. Chiou, Y.T. Huang, Association of pregnancy outcomes in women with type 2 diabetes treated with metformin versus insulin when becoming pregnant. BMC Pregnancy Childbirth 20 (2020). https:\/\/doi.org\/10.1186\/S12884-020-03207-0","DOI":"10.1186\/S12884-020-03207-0"},{"key":"3550_CR56","doi-asserted-by":"publisher","unstructured":"J.E. Given, M. Loane, E. Garne, M.C. Addor, M. Bakker, B. Bertaut-Nativel et al. Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study. BMJ 361 (2018). https:\/\/doi.org\/10.1136\/BMJ.K2477","DOI":"10.1136\/BMJ.K2477"},{"key":"3550_CR57","doi-asserted-by":"publisher","unstructured":"J.L. Tarry-Adkins, C.E. Aiken, S.E. Ozanne, Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: a systematic review and meta-analysis. PLoS Med. 16 (2019). https:\/\/doi.org\/10.1371\/JOURNAL.PMED.1002848","DOI":"10.1371\/JOURNAL.PMED.1002848"},{"key":"3550_CR58","doi-asserted-by":"publisher","first-page":"F488","DOI":"10.1136\/ARCHDISCHILD-2015-309602","volume":"101","author":"TA Wouldes","year":"2016","unstructured":"T.A. Wouldes, M. Battin, S. Coat, E.C. Rush, W.M. Hague, J.A. Rowan, Neurodevelopmental outcome at 2 years in offspring of women randomised to metformin or insulin treatment for gestational diabetes. Arch. Dis. Child Fetal Neonatal Ed 101, F488\u201393 (2016). https:\/\/doi.org\/10.1136\/ARCHDISCHILD-2015-309602","journal-title":"Arch. Dis. Child Fetal Neonatal Ed"},{"key":"3550_CR59","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1210\/jc.2017-02419","volume":"103","author":"L Guro","year":"2018","unstructured":"L. Guro, E. Hanem, S. Stridsklev, \u00d8. Salvesen, M. Roelants, S.M. Carlsen et al. Metformin use in PCOS pregnancies increases the risk of offspring overweight at 4 years of age: follow-up of two RCTs. J. Clin. Endocrinol. Metab. 103, 1612\u201321 (2018). https:\/\/doi.org\/10.1210\/jc.2017-02419","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3550_CR60","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/1753-0407.12813","volume":"10","author":"SA Paschou","year":"2018","unstructured":"S.A. Paschou, B.H.R. Wolffenbuttel, Metformin use during pregnancy: is it really safe? J. Diabetes 10, 984\u20135 (2018). https:\/\/doi.org\/10.1111\/1753-0407.12813","journal-title":"J. Diabetes"},{"key":"3550_CR61","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1093\/HUMREP\/DES264","volume":"27","author":"P Tartarin","year":"2012","unstructured":"P. Tartarin, D. Moison, E. Guibert, J. Dupont, R. Habert, V. Rouiller-Fabre et al. Metformin exposure affects human and mouse fetal testicular cells. Hum. Reprod. 27, 3304\u201314 (2012). https:\/\/doi.org\/10.1093\/HUMREP\/DES264","journal-title":"Hum. Reprod."},{"key":"3550_CR62","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1900\/RDS.2016.13.59","volume":"13","author":"K Tertti","year":"2016","unstructured":"K. Tertti, J. Toppari, H.E. Virtanen, S. Sadov, T. R\u00f6nnemaa, Metformin treatment does not affect testicular size in offspring born to mothers with gestational diabetes. Rev. Diabet. Stud. 13, 59 (2016). https:\/\/doi.org\/10.1900\/RDS.2016.13.59","journal-title":"Rev. Diabet. Stud."},{"key":"3550_CR63","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1124\/dmd.109.031245","volume":"38","author":"S Eyal","year":"2010","unstructured":"S. Eyal, T.R. Easterling, D. Carr, J.G. Umans, M. Miodovnik, G.D. Hankins et al. Pharmacokinetics of metformin during pregnancy. Drug Metab. Distrib. 38, 833\u201340 (2010). https:\/\/doi.org\/10.1124\/dmd.109.031245","journal-title":"Drug Metab. Distrib."},{"key":"3550_CR64","doi-asserted-by":"publisher","unstructured":"M.D. Owen, B.C. Baker, E.M. Scott, K. Forbes, Interaction between metformin, folate and vitamin B12 and the potential impact on fetal growth and long-term metabolic health in diabetic pregnancies. Int. J. Mol. Sci. 22 (2021). https:\/\/doi.org\/10.3390\/IJMS22115759","DOI":"10.3390\/IJMS22115759"},{"key":"3550_CR65","doi-asserted-by":"publisher","first-page":"367.e1","DOI":"10.1016\/J.AJOG.2018.06.013","volume":"219","author":"LA Barbour","year":"2018","unstructured":"L.A. Barbour, C. Scifres, A.M. Valent, J.E. Friedman, T.A. Buchanan, D. Coustan et al. A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes. Am. J. Obstet. Gynecol. 219, 367.e1 (2018). https:\/\/doi.org\/10.1016\/J.AJOG.2018.06.013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"3550_CR66","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/BF00400248","volume":"35","author":"CN Hales","year":"1992","unstructured":"C.N. Hales, D.J.P. Barker, Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35, 595\u2013601 (1992). https:\/\/doi.org\/10.1007\/BF00400248","journal-title":"Diabetologia"},{"key":"3550_CR67","doi-asserted-by":"publisher","unstructured":"H. Salom\u00e4ki, M. Hein\u00e4niemi, L.H. V\u00e4h\u00e4talo, L. Ailanen, K. Eerola, S.T. Ruohonen et al. Prenatal metformin exposure in a maternal high fat diet mouse model alters the transcriptome and modifies the metabolic responses of the offspring. PLoS ONE 9 (2014). https:\/\/doi.org\/10.1371\/journal.pone.0115778","DOI":"10.1371\/journal.pone.0115778"},{"key":"3550_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddis.2017.392","volume":"8","author":"J Deng","year":"2017","unstructured":"J. Deng, M. Mueller, T. Geng, Y. Shen, Y. Liu, P. Hou et al. H19 lncrna alters methylation and expression of hnf4\u03b1 in the liver of metformin-exposed fetuses. Cell Death Dis. 8, 1\u20138 (2017). https:\/\/doi.org\/10.1038\/cddis.2017.392","journal-title":"Cell Death Dis."},{"key":"3550_CR69","doi-asserted-by":"publisher","unstructured":"H. Salom\u00e4ki, L.H. V\u00e4h\u00e4talo, K. Laurila, N.T. J\u00e4ppinen, A.M. Penttinen, L. Ailanen et al. Prenatal metformin exposure in mice programs the metabolic phenotype of the offspring during a high fat diet at adulthood. PLoS ONE 8 (2013). https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0056594","DOI":"10.1371\/JOURNAL.PONE.0056594"},{"key":"3550_CR70","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ebiom.2018.08.047","volume":"35","author":"L Nguyen","year":"2018","unstructured":"L. Nguyen, S.-Y. Chan, A.K.K. Teo, Metformin from mother to unborn child - are there unwarranted effects? EBioMedicine 35, 394\u2013404 (2018). https:\/\/doi.org\/10.1016\/j.ebiom.2018.08.047","journal-title":"EBioMedicine"},{"key":"3550_CR71","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/J.PLACENTA.2021.02.021","volume":"107","author":"AR Anness","year":"2021","unstructured":"A.R. Anness, A. Baldo, D.R. Webb, A. Khalil, T.G. Robinson, H.A. Mousa, Effect of metformin on biomarkers of placental- mediated disease: a systematic review and meta-analysis. Placenta 107, 51\u20138 (2021). https:\/\/doi.org\/10.1016\/J.PLACENTA.2021.02.021","journal-title":"Placenta"},{"key":"3550_CR72","doi-asserted-by":"publisher","unstructured":"F. Wang, G. Cao, W. Yi, L. Li, X. Cao, Effect of metformin on a preeclampsia-like mouse model induced by high-fat diet. Biomed. Res. Int. 2019 (2019). https:\/\/doi.org\/10.1155\/2019\/6547019","DOI":"10.1155\/2019\/6547019"},{"key":"3550_CR73","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/FCP.12501","volume":"33","author":"J Hu","year":"2019","unstructured":"J. Hu, J. Zhang, B. Zhu, Protective effect of metformin on a rat model of lipopolysaccharide-induced preeclampsia. Fundam. Clin. Pharmacol. 33, 649\u201358 (2019). https:\/\/doi.org\/10.1111\/FCP.12501","journal-title":"Fundam. Clin. Pharmacol."},{"key":"3550_CR74","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1136\/bmj.n2103","volume":"374","author":"CA Cluver","year":"2021","unstructured":"C.A. Cluver, R. Hiscock, E.H. Decloedt, D.R. Hall, S. Schell, B.W. Mol et al. Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial. BMJ 374, 2103 (2021). https:\/\/doi.org\/10.1136\/bmj.n2103","journal-title":"BMJ"},{"key":"3550_CR75","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.diabres.2012.09.031","volume":"98","author":"S Niromanesh","year":"2012","unstructured":"S. Niromanesh, A. Alavi, F.R. Sharbaf, N. Amjadi, S. Moosavi, S. Akbari, Metformin compared with insulin in the management of gestational diabetes mellitus: A randomized clinical trial. Diabetes Res. Clin. Pract. 98, 422\u20139 (2012). https:\/\/doi.org\/10.1016\/j.diabres.2012.09.031","journal-title":"Diabetes Res. Clin. Pract."},{"key":"3550_CR76","doi-asserted-by":"publisher","first-page":"34.e1","DOI":"10.1016\/j.ajog.2013.03.022","volume":"209","author":"CP Spaulonci","year":"2013","unstructured":"C.P. Spaulonci, L.S. Bernardes, T.C. Trindade, M. Zugaib, R.P.V. Francisco, Randomized trial of metformin vs insulin in the management of gestational diabetes. Am. J. Obstet. Gynecol. 209, 34.e1\u201334.e7 (2013). https:\/\/doi.org\/10.1016\/j.ajog.2013.03.022","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03550-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03550-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03550-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T08:19:59Z","timestamp":1707293999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03550-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":76,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["3550"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03550-0","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,5]]},"assertion":[{"value":"1 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}